2024 |
Autolus Therapeutics plc - ADR
|
- |
28.1 K |
- |
2024 |
Xeris Biopharma Holdings Inc
|
Independent Director |
- |
- |
2024 |
Applied Therapeutics Inc
|
Executive Chairman of the Board |
- |
- |
2023 |
Axogen Inc.
|
Independent Director |
215.0 K |
18.3 % |
2023 |
Xeris Biopharma Holdings Inc
|
- |
168.3 K |
49.9 % |
2023 |
Verastem Inc
|
- |
81.3 K |
-26.2 % |
2022 |
Axogen Inc.
|
Independent Director |
181.8 K |
-42.4 % |
2022 |
Autolus Therapeutics plc - ADR
|
Chairman of the Board |
161.7 K |
147.2 % |
2022 |
Xeris Biopharma Holdings Inc
|
Independent Director |
112.2 K |
180.1 % |
2022 |
Verastem Inc
|
Independent Director |
110.2 K |
-16.1 % |
2021 |
Axogen Inc.
|
Director |
315.6 K |
- |
2021 |
Verastem Inc
|
Independent Director |
131.4 K |
-2.1 % |
2021 |
Autolus Therapeutics plc - ADR
|
Chairman of the Board |
65.4 K |
- |
2021 |
Xeris Biopharma Holdings Inc
|
Independent Director |
40.1 K |
- |
2020 |
Verastem Inc
|
Independent Director |
134.2 K |
- |
2019 |
Ocugen Inc
|
- |
13.2 K |
-87.9 % |
2019 |
Ocugen Inc
|
Independent Director |
- |
- |
2018 |
Ocugen Inc
|
Independent Director |
109.3 K |
42.1 % |
2017 |
Ocugen Inc
|
Independent Director |
76.9 K |
24.0 % |
2016 |
Ocugen Inc
|
Independent Director |
62.0 K |
-53.8 % |
2015 |
Ocugen Inc
|
Independent Director |
134.2 K |
3073.3 % |
2014 |
Ocugen Inc
|
Independent Director |
4.2 K |
-91.9 % |
2013 |
Ocugen Inc
|
Independent Director |
52 K |
- |